Dermaceutic has been available in Europe for over 20 years with over one million treatments performed. The Spot Treatment system was created as an alternative to treatments containing hydroquinone. In a clinical study patients with melasma achieved 60% improvement in 2 weeks on the Spot Treatment System and 90% achieved excellent improvement after 4 weeks*.
- What causes melasma?
Genetics, hormones such as estrogen and progesterone, and extrinsic factors such as sun exposure cause melasma. Hormones stimulate the production of melanocytes, the pigment producing cells in our skin, as they become exposed by the sun. The increased melanin production causes the spotting we see with melasma.
- What should I expect after my In-Office Spot Treatment?
Your skin might be pink and you will experience mild flaking beginning a few days after the in office treatment.
- Is the Spot Treatment System safe on darker skin types?
Every product in the Spot Treatment System is suitable for all skin types.
- What causes Post-inflammatory hyperpigmentation?
Post-inflammatory hyperpigmentation is caused by skin infections, allergic reactions, adverse reactions to lasers, burns, and other inflammatory reactions including acne.
Ask us about incorporating the Dermaceutic Spot Treatment System into your regimen today.
*Data on file.